[Home ]    
:: Home :: About Conference :: Registration :: Article Submission :: Contact us :: Site Map ::
Main Menu
About Conference::
Conference Organization::
Abstract Submission::
Contact us::
Peripheral Programs::
Site Facilities::




Mazndaran University of Medical Sciences  

Invasive Fungi Research Center

 Iranian Society of Medical Mycology Radboud university medical center

Tıbbi Mikoloji Derneği AWT IMAGE

Cancer Research Center





:: invited speakers ::


Prof. David W. Denning

Professor of Infectious Diseases in Global Health

David Denning is an internationally recognized clinician with expertise in fungal diseases. He manages the UK’s National Aspergillosis Centre in Manchester, the world’s only such center. David Denning has published more than 500 papers, books and book chapters and lectures worldwide. His writings have been cited over 40,000 times and he has successfully lead many major international collaborative science, diagnostic and treatment projects and clinical guidelines, with subsequent publication in Nature, the New England Journal of Medicine and the Lancet. He is the Founder of two University spinout biotechnology companies – F2G Ltd (antifungal drug discovery and development) and Myconostica Ltd (molecular diagnostic tests for fungi), now owned by Lab21.
David is Chairman of the Editorial Board of The Aspergillus Website (1998- ) with over 1 million pages read per month. He has chaired the Scientific Committees of several international fungal infection meetings and co-chairs the alternate year Advances Against Aspergillosis meetings, attracting ~400 delegates from >120 countries.


Prof. Macit İlkit, M.D., Ph.D

Macit Ilkit  is a Professor of Microbiology in the Faculty of Medicine at the University of Çukurova, Adana, Turkey and serves as director of the Division of Medical Mycology. He graduated from the same faculty and defended his Ph. D. in 1995. He has been actively involved in dermatophytes and dermatophytosis research, with an interest in epidemiology and diagnosis. He was also one of the founders of the Society of Medical Mycology in Turkey, which was established in December 2011. Currently, he serves as an Associate Editor/Editorial Board member for the internationally peer-reviewed journals Mycopathologia, Biomed Research International Infectious Diseases, and Medical Mycology.  

Prof. Dr. Paul E. VERWEIJ,

Prof. Paul E. Verweij, MD, PhD

Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands

Paul Verweij is the professor of medical microbiology and consultant microbiologist at the Department of Medical Microbiology at Radboudumc in Netherlands. His main research interests include diagnosis of invasive aspergillosis, resistance in molds, and clinical studies of new antifungal agents. He has published several papers on the relationship between resistance to medical triazoles in the opportunistic fungus Aspergillus fumigatus and the use of azole fungicides for crop protection and material preservation.


Dr. Amir (Seyedmojtaba) Seyedmousavi, PhD

 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH), Bethesda, MD, USA.

Amir (Seyedmojtaba) Seyedmousavi is a Ph.D Medical/Molecular Mycologist and Research Scientist in Medical Microbiology & Infectious Diseases.

His current research, at the lab of Dr. Kwon-Chung at the National Institutes of Health, Bethesda, Maryland, focuses on molecular mycology, pathobiology, and immunology of chronic and invasive aspergillosis caused by multi-resistant cryptic species of Aspergillus.

Amir was born in Khomam, a small City in Rasht County, Gilan Province, North of Iran on the 21st September 1977. After finishing high school (1995) in “Biology and Natural Sciences” in his hometown, he completed his undergraduate studies at the University of Tehran, Iran in 2002, followed by a Ph.D (Cum Laude) in Mycology in 2006, under the supervision of Prof. S.J Hashemi and Prof. A.R. Khosravi.  He was also appointed as Lecturer and Assistant Professor of Medical Mycology in Iran between 2002 to 2009.

He then moved to Netherlands and did his first postdoctoral research (2009-2010) in molecular mycology, taxonomy and phylogeny of melanized fungi in the lab of Prof. Sybren de Hoog at the CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands.

Between 2010 to 2016, he also completed his postdoctoral training programs subject Aspergillus fumigatus, molecular epidemiology of Antifungal-resistance and preclinical Pharmacokinetics and Pharmacodynamics (PK/PD) strategies to treat invasive fungal infections at the Departments of Medical Microbiology, RadboudUMC, Nijmegen, and ErasmusUMC, Rotterdam, the Netherlands, under supervision of Prof. Paul Verweij, Prof. Johan Mouton and Dr. Willem Melchers. In 2014 Amir also succeeded with honor in a second Ph.D examination, subject Medical Mycology and PK/PD, at the Radboud University Medical Center, Nijmegen, The Netherlands.

He teaches internationally on a number of basic and advanced postgraduate courses/workshops on various aspects of Medical and Veterinary Mycology.

Since 2014, he serves as an Editor of Medical Mycology journal, published by Oxford University Press on behalf of International Society for Human and Animal Mycology (ISHAM) (http://mmy.oxfordjournals.org/)

He is also Ambassador of Science (Science Diplomat) to IRAN at American Society for Microbiology (www.asm.org).  


Dr. Willem JG Melchers 

Associate Professor in Molecular Microbiology

Head of Department Medical Microbiology Laboratory, Radboud University Medical Centre Nijmegen

Scientific Memberships:

 Netherlands Society of Medical Microbiology

 American Society for Microbiology

 Netherlands Society for Biochemistry and Molecular Biology

 European Group of Rapid Viral Diagnosis


 Head Clinical Laboratory Medical Microbiology (Chef de Laboratoire), Department of Medical Microbiology

 CEO NovioGendix Holding BV

 Head section Molecular Microbiology & Diagnostics, Department of Medical Microbiology

 Board Member Management Team Department of Medical Microbiology

 Board Member (Treasurer) Netherlands Society for Medical Microbiology (2006-2010)

 Chairman Member Concilium Molecular Medical Microbiologists (MMM) (2009-)

 Chairman Seminar Committee Graduate School Institute of Cellular Signaling (1999-2005)

 Chairman Research Committee Department of Medical Microbiology (1996-2006)

 Chairman Professional Committee Medical Microbiological Researchers (BBC) (1998-2008)

 Board Member Research Council Nijmegen Center for Molecular Life Sciences (2000-2005)

 Board Member National Committee for Medical-Biological Research Netherlands (NijmegenbUniversity-delegate) (2004-2008)

 Board Member Foundation Luis Pasteur (2000-2009)

 Educator Medical Microbiological Researchers (UMC Nijmegen) (2008-)

 Member NCMLS Research Committee - Grant-assessment (1999-2006)

 Member Dutch Working Group Molecular Diagnostics of Infectious Diseases (1999-)


Prof Sülyha Hilmioğlu Polat,  MD

Department of Medical Microbiology

Faculty of Medicine, Ege University, Izmir, Turkey

Sülyha HİLMİOĞLU POLAT, MD, is a Professor of Medical Microbiology in the Faculty of Medicine, Ege University, Izmir, Turkey. She received her MD and Clinical Microbiology and Infectious Diseases specialist degree from the same university. Her topic of interest is the laboratory diagnosis of fungal infections. She is one of the founder members of Turkish Society of Medical Mycology and at present she is the general secretary of the society .


Dr. Emmanuel Roilides, MD, PhD, FIDSA, FAAM
Professor of Pediatrics – Infectious Diseases
Head, Infectious Diseases Unit and Research Laboratory, Univ of Thessaloniki, Greece

Dr. Emmanuel Roilides holds doctoral degrees in Medicine (MD) and Microbiology (PhD) from Athens University (AU) School of Medicine, and Board Certifications in Pediatrics and Pediatric Infectious Diseases from the Greek Ministry of Health. Following extensive training at the NIH, he was recruited to Aristotle University School of Medicine, where he rose to become Professor of Pediatrics, Chief of Pediatric Infectious Diseases, and Founding Director of the Infectious Diseases Research Laboratory. The author or co-author of >450 publications, Emmanuel has made fundamental, extensive, and enduring advances in four key areas: innate host defenses against Candida spp., Aspergillus spp., and emerging fungal pathogens; epidemiology and treatment of pediatric mycoses; mentoring postdoctoral research fellows in pediatric infectious diseases; and fulfillment of key leadership positions in scientific societies. As a recipient of numerous grants and research awards, he has built the leading laboratory of innate host defenses and pediatric mycology in Greece and one of the premier programs in EU. Emmanuel has served in key leadership positions in the European Confederation for Medical Mycology, European Society for Pediatric Infectious Diseases, and International Immunocompromised Host Society. He is a Fellow of the Infectious Diseases Society of America, serves on editorial boards of six biomedical journals, and reviewer for >50 journals. He has trained >25 post-doctoral fellows with dissertations.

View: 2898 Time(s)   |   Print: 423 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)
:: Weather Forecast ::
 | Post date: 2016/07/18 | 
View: 1590 Time(s)   |   Print: 145 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)
:: welcome:: ::
 | Post date: 2016/07/24 | 
Abstract Submissions Deadline: 21 Sep, 2016, 11:59 P

اولین کنفرانس بین المللی قارچ شناسی بالینی: آسپرژیلوس و آسپرژیلوزیس

1st IFRC International Clinical Mycology Conference: Aspergillus and Aspergillosis


On behalf of the Organizing Committee, I am really pleased to announce the 1st IFRC International Conference on Clinical Mycology, Aspergillus and Aspergillosis will be held in Sari, Mazandaran, Iran from Nov 8 to Nov 10, 2016.

1st IFRC International Conference on Clinical MycologyAspergillus and Aspergillosis is a way to bring together researchers on Aspergillus, medical mycologists and other related specialists including medical microbiologists, hematologists, oncologists, transplant physicians, immunologists, dermatologists, pediatricians, and all those with interests in medical mycology. The conference will encompass all of the fields of clinical mycology with particular attention being paid to the major challenges on the Aspergillus and aspergillosis including "taxonomy", "genetics", "immunity", "epidemiology", "antifungal susceptibility", "management strategies", "diagnosis" and "clinical presentations" to "future challenges". 

1st IFRC International Conference on Clinical Mycology, Aspergillus and Aspergillosis will give you the opportunity to meet some experts around the world, share your studies, and interact with your peers in Sari.

 It is located in Mazandaran, the north of Iran, between the northern slopes of the Alborz Mountains and southern coast of the Caspian Sea. It also gives you to visit the sandy beach, beautiful waves and jungle suitable for sunbathing, swimming and recreation.

We look forward to meeting you in Nov 2016, in Sari, Mazandaran.

Sincerely yours

Mohammad T. Hedayati, PhD

Professor of Medical Mycology 

Director, Invasive Fungi Research Center

Head of department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences

View: 1185 Time(s)   |   Print: 77 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)
1st Ifrc International Clinical Mycology Conference: Aspergillus and Aspergillosis